Literature DB >> 23390300

Pathogenesis of accelerated fibrosis in HIV/HCV co-infection.

Wenyu Lin1, Ethan M Weinberg, Raymond T Chung.   

Abstract

Human immunodeficiency virus (HIV) infection is a major cause of acceleration of hepatitis C virus-related liver disease, cirrhosis, and death. However, studies of liver disease pathogenesis in HIV/HCV coinfection have thus far been limited. Emerging data support multiple derangements attending HIV coinfection, including increases in profibrogenic cytokine expression and secretion, generation of enhanced oxidative stress, and increases in hepaotcyte apoptosis. These derangements may be further augmented in the presence of increased microbial translocation in the setting of HIV disease. New insight into the mechanisms of HIV/HCV pathogenesis causing accelerated liver fibrosis could lead to new therapeutic strategies designed to retard ths process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23390300      PMCID: PMC3611768          DOI: 10.1093/infdis/jis926

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

Authors:  Colette Smith; Caroline A Sabin; Jens D Lundgren; Rodolphe Thiebaut; Rainer Weber; Matthew Law; Antonella d'Arminio Monforte; Ole Kirk; Nina Friis-Moller; Andrew Phillips; Peter Reiss; Wafaa El Sadr; Christian Pradier; Signe W Worm
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 2.  Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations.

Authors:  Jinah Choi
Journal:  Free Radic Biol Med       Date:  2012-01-25       Impact factor: 7.376

3.  Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.

Authors:  Ana C Tuyama; Feng Hong; Yedidya Saiman; Chuansheng Wang; Derya Ozkok; Arevik Mosoian; Ping Chen; Benjamin K Chen; Mary E Klotman; Meena B Bansal
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

4.  All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.

Authors:  Victoria Hernando; Santiago Perez-Cachafeiro; Charlotte Lewden; Juan Gonzalez; Ferran Segura; Jose Antonio Oteo; Rafael Rubio; David Dalmau; Santiago Moreno; Julia Del Amo
Journal:  J Hepatol       Date:  2012-06-16       Impact factor: 25.083

5.  HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis.

Authors:  Jennifer C Price; Eric C Seaberg; Sheila Badri; Mallory D Witt; Kristin D'Acunto; Chloe L Thio
Journal:  J Infect Dis       Date:  2012-01-30       Impact factor: 5.226

6.  HIV infection increases HCV-induced hepatocyte apoptosis.

Authors:  Jae Young Jang; Run-Xuan Shao; Wenyu Lin; Ethan Weinberg; Woo Jin Chung; Wei Lun Tsai; Hong Zhao; Kaku Goto; Leiliang Zhang; Jorge Mendez-Navarro; Nikolaus Jilg; Lee F Peng; Mark A Brockman; Raymond T Chung
Journal:  J Hepatol       Date:  2010-09-29       Impact factor: 25.083

7.  Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.

Authors:  Netanya G Sandler; Christopher Koh; Annelys Roque; Jason L Eccleston; Rebecca B Siegel; Mary Demino; David E Kleiner; Steven G Deeks; T Jake Liang; Theo Heller; Daniel C Douek
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

8.  Human immunodeficiency virus and liver disease forum 2010: conference proceedings.

Authors:  Kenneth E Sherman; David L Thomas; Raymond T Chung
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

9.  Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication.

Authors:  Lance D Presser; Adam Haskett; Gulam Waris
Journal:  Virology       Date:  2011-02-05       Impact factor: 3.616

10.  HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.

Authors:  Wenyu Lin; Guoyang Wu; Shaoyong Li; Ethan M Weinberg; Kattareeya Kumthip; Lee F Peng; Jorge Méndez-Navarro; Wen-Chi Chen; Nikolaus Jilg; Hong Zhao; Kaku Goto; Leiliang Zhang; Mark A Brockman; Detlef Schuppan; Raymond T Chung
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

View more
  43 in total

1.  Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.

Authors:  Victoria N Parikh; Joseph Park; Ivana Nikolic; Richard Channick; Paul B Yu; Teresa De Marco; Priscilla Y Hsue; Stephen Y Chan
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

2.  The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.

Authors:  Fabio C O F Cachem; Aleida S Dias; Clarice Monteiro; José Roberto Castro; Gabriel Fernandes; Letícia Delphim; Adilson J Almeida; Felipe Tavares; Alessandra M A Maciel; Marcia M Amendola-Pires; Carlos E Brandão-Mello; Cleonice A M Bento
Journal:  Immunology       Date:  2017-03-13       Impact factor: 7.397

Review 3.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

4.  Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.

Authors:  P R Allyn; S M O'Malley; J Ferguson; C H Tseng; K W Chew; D Bhattacharya
Journal:  Int J STD AIDS       Date:  2017-08-18       Impact factor: 1.359

5.  Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.

Authors:  Jessie Torgersen; Tamar H Taddei; Lesley S Park; Dena M Carbonari; Michael J Kallan; Kisha Mitchell Richards; Xuchen Zhang; Darshana Jhala; Norbert Bräu; Robert Homer; Kathryn D'Addeo; Rajni Mehta; Melissa Skanderson; Farah Kidwai-Khan; Amy C Justice; Vincent Lo Re
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-01       Impact factor: 4.254

6.  Human immunodeficiency virus and liver disease forum 2012.

Authors:  Kenneth E Sherman; David Thomas; Raymond T Chung
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

7.  Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression.

Authors:  Murali Ganesan; Raghubendra Singh Dagur; Edward Makarov; Larisa I Poluektova; Srivatsan Kidambi; Natalia A Osna
Journal:  Biochem Biophys Res Commun       Date:  2018-04-22       Impact factor: 3.575

Review 8.  HIV, Aging, and Viral Coinfections: Taking the Long View.

Authors:  Tamar H Taddei; Vincent Lo Re; Amy C Justice
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

9.  Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Authors:  Vincent Lo Re; Michael J Kallan; Janet P Tate; A Russell Localio; Joseph K Lim; Matthew Bidwell Goetz; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Lesley Park; Robert Dubrow; K Rajender Reddy; Jay R Kostman; Brian L Strom; Amy C Justice
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

Review 10.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.